| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Biodrain Medical Inc | |
|---|---|
| Ticker | AGPU |
| CIK # | 0001446159 |
| CUSIP | 74039M408 |
| Sector | Life Sciences - Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Address | 2060 Centre Pointe Boulevard Suite 7, Mendota Heights, MN 55120 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Predictive Oncology Inc | 2025-10-22 | 50.8 M | Exemption: 506(b) · Duration: One year or less · Commission: $2,538,481 · Revenue: Decline to Disclose |
| Precision Therapeutics Inc | 2018-10-11 | 2.0 M | Exemption: 506(b) · Minimum: $600,000 · Remaining: $500,000 · Duration: One year or less · Commission: $160,000 · Revenue: Decline to Disclose |
| Skyline Medical Inc | 2017-12-12 | 1.3 M | Exemption: 506(b) · Minimum: $1,300,000 · Duration: One year or less · Commission: $104,000 · Revenue: Decline to Disclose |
| Biodrain Medical Inc | 2013-06-03 | 1.0 M | Exemption: 505, 506 · Minimum: $25,000 · Duration: One year or less · Commission: $80,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001446159] | 10-K | |
| [0001446159] | 10-Q | |
| [0001446159] | 3 | |
| [0001446159] | 4 | |
| [0001446159] | 8-K | |
| [0001446159] | D | |
| [0001446159] | SC 13D | |
| [0001446159] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miglino Christopher
Non-Qualified Stock Options · derivative
|
2026-02-09 | Grant | 500,000 | $0.00 | |
|
Vennare Raymond F
Common Stock
|
2026-02-05 | Tax withheld | 6,758 | $2.59 | 17,503 |
|
Vennare Raymond F
Common Stock
|
2025-12-10 | Grant | 20,000 | $0.00 | |
|
Vennare Raymond F
Common Stock
|
2025-11-28 | Tax withheld | 2,373 | $5.90 | 14,001 |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 124,959 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 97,000 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Common Stock
|
2025-09-09 | Grant | 64,680 | $0.00 | |
|
Rao Veena
Common Stock
|
2024-04-05 | Grant | 3,268 | $0.00 | |
|
Chung-Welch Nancy
Common Stock
|
2024-04-05 | Grant | 2,353 | $0.00 | |
|
St Clair Gregory SR
Common Stock
|
2024-04-05 | Grant | 3,268 | $0.00 | |
|
Hawryluk Matthew
Common Stock
|
2024-04-05 | Grant | 2,368 | $0.00 | |
|
Handley Daniel E
Common Stock
|
2024-04-05 | Grant | 2,353 | $0.00 | |
|
Nuzum Charles Lee Sr
Common Stock
|
2024-04-05 | Grant | 3,268 | $0.00 | |
|
Nuzum Charles Lee Sr
Common Stock
|
2023-10-02 | Grant | 2,605 | $0.00 | |
|
Rao Veena
Common Stock
|
2023-10-02 | Grant | 1,875 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 14 | 339,917 |
| 2025-12-31 | 15 | 151,153 |
| 2025-09-30 | 6 | 22,024 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Wolff Wiese Magana LLC | [2026-06-30] | SOLE | 250 | 250 | Prev | Page 1 | Next |